Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 5/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.31 |
| ▸ | TEK | Q02763 | 1/20 | 0.31 |
| ▸ | GLS2 | Q9UI32 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13267620 | 0.83 | ALOX5 (0.47) | ALOX5PTGS2PTGS1KDM4EMEN1 | |
| SCHEMBL7886293 | 0.78 | ALOX5 (0.37) | ALOX5PTGS2GLS2 | |
| SCHEMBL2404062 | 0.78 | HKDC1 (0.61) | ALOX5PTGS2KDM4EMEN1USP2 | |
| SCHEMBL5145016 | 0.72 | MAOA (0.48) | MEN1MAPTMAPK1KMT2AHKDC1 | |
| SCHEMBL18135602 | 0.71 | — | — | |
| SCHEMBL12848243 | 0.71 | ALOX5 (0.31) | ALOX5PTGS2KDM4EMEN1USP2 | |
| SCHEMBL12795822 | 0.71 | PIM1 (0.43) | ALOX5PTGS2KDM4EMEN1USP2 | |
| SCHEMBL5712779 | 0.69 | STAT3 (0.37) | HKDC1 | |
| SCHEMBL5712767 | 0.69 | PIM1 (0.31) | — | |
| SCHEMBL15761111 | 0.67 | ATM (0.38) | MAPTKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110053276-A1 | MOLECULAR INDICATOR AND PROCESS OF SYNTHESIZING | BATTELLE MEMORIAL INSTITUTE | 2011-03-03 | — | — | US | disclosed |
| US-20110053276-A1 | MOLECULAR INDICATOR AND PROCESS OF SYNTHESIZING | BATTELLE MEMORIAL INSTITUTE | 2011-03-03 | — | — | US | disclosed |
| EP-1436407-B1 | AMPEROMETRIC SENSOR | DREW SCIENT CO LTD (US) | 2006-12-06 | — | — | EP | disclosed |
| US-20040265940-A1 | Amperometer sensor | DREW SCIENTIFIC HOLDINGS, INC. | 2004-12-30 | — | — | US | disclosed |
| US-4769436-A | ADHESIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1988-09-06 | — | — | US | disclosed |
| EP-0027202-B1 | PROCESS FOR PREPARING FIBRE-REINFORCED MOULDED ARTICLES | BAYER AG (DE) | 1983-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110053276-A1 | MOLECULAR INDICATOR AND PROCESS OF SYNTHESIZING | MUS81, MKI67, AOC1 | ALOX5 3789/4885PTGS2 2820/4885PTGS1 2881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.